COVID-19 vaccine-associated myocarditis (C-VAM) has a mild initial clinical course, but myocardial injury is common, ...

A new study looked at the long-term prognosis of French people who were hospitalised between 2020 and 2022 for heart ...

Purpose: The treatment options for viral myocarditis caused by coxsackievirus B are summarized. Summary: Myocarditis is a common cause of dilated cardiomyopathy. The most common causes of ...

Myocarditis is the inflammation of the heart muscle—also known as the myocardium. Symptoms of myocarditis vary widely, depending on the extent and severity of inflammation that you're experiencing and ...

Even though most of the time, it is nothing to worry about, however, many experts feel it can be a sign of myocarditis - a ...

The new COVID-19 vaccines based on mRNA technology are no exception. But one risk associated with them—myocarditis, especially for young men—has raised concerns among the public. A new study ...

Even with a low rates of cardiovascular adverse events in patients treated with immune checkpoint inhibitors, cancer care ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window People with postvaccine myocarditis did not share the typical mid-term complications associated with conventional ...

Mean treatment duration (months) 8.1 ± 0.7 8.7 ± 1.4 8.2 ± 1.6 8.6 ± 1.2 a All groups were treated with conventional heart failure therapy (digoxin, diuretics, and vasodilators) throughout the ...

Most of the time, this is nothing to worry about, but it can be a sign of myocarditis - a condition that kills one young person suddenly every week in the UK. Worryingly though, most Brits wouldn ...

Introduction Wearable cardioverter-defibrillators (WCD) have emerged as a valuable tool in the management of patients at risk ...